EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Management of hypertriglyceridemia-induced acute pancreatitis in the intensive care unit: A narrative review

Erica Thacker, John Wageh, Susan E Smith

American Journal of Health-System Pharmacy · 2026

DOI: 10.1093/ajhp/zxaf347 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift American Journal of Health-System Pharmacy, 2026. Verfasst von Erica Thacker und 2 weiteren Autor:innen. Beteiligte Einrichtung: Research Medical Center, Kansas City, MO, USA. Hauptthemen laut MEDLINE: Hypertriglyceridemia, Pancreatitis, Intensive Care Units, Disease Management. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 50 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Severe hypertriglyceridemia causing acute pancreatitis may necessitate intensive care unit (ICU) admission. Management of hypertriglyceridemia in this setting requires therapies that result in rapid triglyceride lowering that are different from therapies used in the outpatient setting. The purpose of this narrative review is to explore strategies for managing hypertriglyceridemia-induced acute pancreatitis (HTGP) in the ICU. Summary Patients may develop acute pancreatitis when triglyceride levels exceed 500 mg/dL, either as their primary reason for admission to the ICU or as an adverse effect of medications received during ICU care. Rapid reduction of triglycerides is attained through activation of lipoprotein lipase (LPL), an enzyme essential for the removal of triglycerides from the plasma. Treatment modalities include therapeutic plasma exchange and the combination of insulin and heparin infusions for acute treatment, although there is no consensus on optimal dosing. Fibrates are recommended as first-line agents in prevention of hypertriglyceridemia-induced pancreatitis in high-risk patients.

Conclusion

Several therapies are used for acute management of HTGP in the ICU setting. Further research is necessary to refine treatment protocols and establish best practices for managing HTGP in critically ill patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HypertriglyceridemiaPancreatitisIntensive Care UnitsDisease ManagementHumansAcute DiseaseHeparinInsulinPlasma ExchangeFibric AcidsHypolipidemic AgentsTriglyceridesCritical Care

Stichwörter der Autor:innen

critical carefibric acidsheparinhypertriglyceridemiainsulinplasma exchange

Substanzen

HeparinInsulinFibric AcidsHypolipidemic AgentsTriglycerides

Autor:innen und Institutionen

  • Research Medical Center, Kansas City, MO, USA.
  • University of Pittsburgh Medical Center, Harrisburg, PA, USA.
  • Department of Clinical and Administrative Pharmacy, University of Georgia College of Pharmacy, Athens, GA, USA.

Zitieren

APA

Thacker, E., Wageh, J., & Smith, S. E. (2026). Management of hypertriglyceridemia-induced acute pancreatitis in the intensive care unit: A narrative review. American Journal of Health-System Pharmacy. https://doi.org/10.1093/ajhp/zxaf347

Vancouver

Thacker E, Wageh J, Smith SE. Management of hypertriglyceridemia-induced acute pancreatitis in the intensive care unit: A narrative review. American Journal of Health-System Pharmacy. 2026. doi:10.1093/ajhp/zxaf347

BibTeX
@article{Thacker2026,
  author = {Thacker, Erica and Wageh, John and Smith, Susan E},
  title = {Management of hypertriglyceridemia-induced acute pancreatitis in the intensive care unit: A narrative review},
  journal = {American Journal of Health-System Pharmacy},
  year = {2026},
  doi = {10.1093/ajhp/zxaf347}
}
Kostenlos starten →